352
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia

, , , , , , ORCID Icon, & ORCID Icon show all
Pages 755-757 | Received 06 Sep 2020, Accepted 20 Oct 2020, Published online: 05 Nov 2020
 

Disclosure statement

No conflict of interest to disclose.

Additional information

Funding

The authors wish to thank Associazione Italiana per la Ricerca sul Cancro (AIRC) 5×1000, Special Program Metastases (21198), Milan (Italy) to RF and GG; Finanziamento Medi Progetti Universitari 2015 (C26A15F9WW, Sapienza University of Rome) and 2018 (RM11816436B712AF, Sapienza University of Rome) to SC and PRIN 2017 (2017PPS2X4_002) to SC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.